Documents > FDA approval


Letter from CFSAN to FDA Experts

FDADocs 5/9/2008 | 0 (0) | 44 | 0 | 0 | English

_`°" DEPA RTME N T OF HEALTH AND HUMAN SERVICES Public Health Service 5100 Paint Branch Parkway Food and Drug Administration College Park, Maryland 20740 MAR 2 9 2006 Irene Gomez, :Regulatory Consultant FDA Experts 3509 W. Beverly Blvd., Montebello, California 90640 Dear Ms Gomez : This is to inform you that the notification, dated August 17, 2 ...  more>>

FDA Dermatology Consult Luke FDA Table of Contents

FDADocs 5/9/2008 | 0 (0) | 76 | 0 | 0 | English

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Division of Dermatologic and Dental Drug Products Office of Drug Evaluation V Center for Drug Evaluation and Research Food and Drug Administration Silver Spring MD 20878 Tel FAX 301-827-2020 301-827-2075 M E M O R A N D U M Date: From: Through: To: Cc: October 11, 2005 Markham C. Luke, M. ...  more>>

CONTENTS Exhibit FDA March letter from Gary

FDADocs 5/9/2008 | 0 (0) | 17 | 0 | 0 | English

CONTENTS Exhibit 1 FDA March 1, 2004 letter from Gary J. Buehler, Director, Office of Generic Drugs, Center for Drug Evaluation.,and; Resepyh $o A@D$I $$plicants for / _” “. Metaxalone Tablets Declaration of Dr. Paul Bass, Professor Emeritus of Pharmacology at the University of W isconsin -- Madison Morey, “Metaxalone, a New Skeletal Muscle Relaxan ...  more>>

Sponsor s Proposed Label FDA Table of Contents

FDADocs 5/9/2008 | 0 (0) | 27 | 1 | 0 | English

NDA 20-717/S-019 November 2005 SPARLON™ (modafinil) Tablets [C-IV] Rx Only DESCRIPTION SPARLON (modafinil) is an orally administered agent for the treatment of AttentionDeficit/Hyperactivity Disorder (ADHD). Modafinil was initially developed and is also marketed as a wakefulness-promoting agent PROVIGIL® Tablets. Modafinil is a racemic compound ...  more>>

FDA Executive Summary Version Prepared for the March - pdf

FDADocs 5/9/2008 | 0 (0) | 37 | 0 | 0 | English

FDA Executive Summary (Version 2) Prepared for the March 27, 2006, meeting of the Obstetrics & Gynecology Devices Panel P050011 Innovata plc ® Adept Adhesion Reduction Solution (4% Icodextrin Solution) 1.) INDICATIONS FOR USE Adept Adhesion Reduction Solution (4% Icodextrin Solution) (Adept®) is intended for use as an adjunct to good surgical techn ...  more>>

Draft Guidance for Industry and FDA Staff Establishing

GovernmentDocs 5/5/2008 | 0 (0) | 52 | 0 | 0 | English

Draft Guidance for Industry and FDA Staff Establishing the Performance Characteristics of In Vitro Diagnostic Devices for the Detection or Detection and Differentiation of Influenza Viruses DRAFT GUIDANCE This guidance document is being distr.ibutedfor comment purposes only. Document issued on: [release date of FR Notice] Comments and suggestions r ...  more>>

FDA Executive Summary Prepared for the November Dental - htm

FDADocs 5/9/2008 | 0 (0) | 38 | 0 | 0 | English

FDA Executive Summary Prepared for the November 9, 2006 Dental Products Panel Company: Device: Document No.: Date: Medtronic Sofamor Danek InFuse® Bone Graft P050053 October 4, 2006 InFuse® Bone Graft is a combination product consisting of a device and a biologic drug. FDA has determined that InFuse® will be reviewed as a PMA device/drug with cons ...  more>>

Heparin Adverse Reactions FDA s Role Main heparin Information

FDADocs 5/9/2008 | 0 (0) | 34 | 0 | 0 | English

Heparin, Adverse Reactions – FDA’s Role Main heparin update page: www.fda.gov/cder/drug/infopage/heparin/default.htm As of March 14, 2008 1 2 3 4 ADVERSE REACTION Some patients experience severe allergic reaction/low blood pressure after receiving heparin. REPORTING A small percentage of adverse reactions are reported to Centers for Disease ...  more>>

Heparin Import Alert FDA s Role Main heparin Information

FDADocs 5/9/2008 | 0 (0) | 41 | 0 | 0 | English

Heparin, Import Alert – FDA’s Role Main heparin update page: www.fda.gov/cder/drug/infopage/heparin/default.htm As of March 14, 2008 1 2 3 4 PRODUCT ENTRY Heparin, including Active Pharmaceutical Ingredient (API) and finished heparin, enter U.S. ports from overseas. IMPORT ALERT FDA issues import alert on shipments from specified manufactur ...  more>>

CALL FOR ABSTRACTS Poster Session on Genomics and FDA Science Forums

FDADocs 5/12/2008 | 0 (0) | 20 | 0 | 0 | English

CALL FOR ABSTRACTS Poster Session on Genomics and Proteomics 10TH Annual FDA Science Forum FDA Science: The Critical Path from Concept to Consumer May 18-19, 2004, Washington Convention Center Co-sponsored by FDA, Williamsburg BioProcessing Foundation, Sigma Xi, AOAC and Prous Science http://www.dcscienceforum.org/ About the FDA Science Forum: T ...  more>>


   
  results / page   15/25/50 Page: 8 of 34 << prev 1...567891011...34 next >>